State Pharmaceutical Corporation OF Pharmaceutical Import Profile — Sri Lanka (DGFT 2022–2026)

Name: State Pharmaceutical Corporation OF Pharmaceutical Import Records from India — 2 Products, $154.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

State Pharmaceutical Corporation OF — Pharmaceutical Importer Profile (2026) | 2 Products, $154.6K Trade | TransData Nexus

State Pharmaceutical Corporation OF

Pharmaceutical Importer · Sri Lanka · Gastrointestinal Focus · $154.6K Total Trade · DGFT Verified

State Pharmaceutical Corporation OF is a pharmaceutical importer based in Sri Lanka with a total trade value of $154.6K across 2 products in 2 therapeutic categories. Based on 5 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. State Pharmaceutical Corporation OF sources from 8 verified Indian suppliers, with Glenmark Pharmaceuticals Limited accounting for 32.9% of imports.

State Pharmaceutical Corporation OF — Import Portfolio & Supplier Network

State Pharmaceutical Corporation OF import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to State Pharmaceutical Corporation OF?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Glenmark Pharmaceuticals Limited	$267.1K	31	32.9%
Mcw Healthcare Private Limited	$154.6K	7	19.1%
Mmc Healthcare Limited	$119.3K	4

What Formulations Does State Pharmaceutical Corporation OF Import?

Formulation	Value	Ships
Inodol 500 tablets paracetamol tablets BP 500MG batch se04301 to se04308 details as per invoice and packing	$100.0K	2
Glucosamine capsules 750MG cartiplus	$100.0K	2
Lactulose solution USP 10g/15ML batch	$100.0K	2
Glenper cream 15 GM	$70.9K	3
Terbutaline syrup 1.5MG/5ML	$54.6K	3
Glix 40 tablets gliclazide tablets i p 40MG 2x5x10s	$50.0K	1
Candid cream 20GM	$46.5K	1
Lizolid 600 tablets 5x1x4s	$46.0K	4
Pharmaceuticals drugs & medicine: ooz	$44.1K	1
Pharmaceuticals drugs & medicine	$29.5K	2
Candid powder 30GM	$25.6K	2
Mumfer syrup 150 ML	$20.5K	5
Glimepiride tablets USP 2 MG	$19.3K	2
Clobetasol propionate USP 0.05 % w/w	$14.5K	1
Momate ointment 15 GM	$13.8K	3

State Pharmaceutical Corporation OF imports 30 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Lactulose	Gastrointestinal	$100.0K	2	0.7%	13
2	Terbutaline	Respiratory & OTC	$54.6K	3	1.6%	6

State Pharmaceutical Corporation OF imports 2 pharmaceutical products across 2 categories into Sri Lanka totaling $154.6K.

State Pharmaceutical Corporation OF — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

The State Pharmaceuticals Corporation (SPC) of Sri Lanka is a state-owned enterprise headquartered in Colombo, Sri Lanka. Established in 1971 under the State Industrial Corporations Act Number 49 of 1957, SPC was founded following the recommendations of the Bibile-Wickramasinghe Commission, which aimed to ensure the availability of quality-assured pharmaceuticals at affordable prices. (spc.lk)

As the largest supplier of drugs in Sri Lanka, SPC plays a pivotal role in the nation's healthcare system. It is responsible for providing a wide range of medicinal products, including pharmaceuticals, surgical consumables, laboratory chemicals, and equipment. Additionally, SPC oversees the Rajya Osusala pharmacy chain, which serves communities nationwide, ensuring access to essential medications. (spc.lk)

2Distribution Network

SPC's distribution network is extensive, encompassing multiple warehouses and logistics centers strategically located across Sri Lanka. This infrastructure enables the corporation to efficiently supply pharmaceuticals and healthcare items to both public and private healthcare institutions. While specific warehouse locations are not publicly disclosed, SPC's operations are designed to ensure timely and widespread distribution of medical supplies throughout the country. (spc.lk)

3Industry Role

In Sri Lanka's pharmaceutical supply chain, SPC functions primarily as a wholesaler and distributor. It serves as the sole supplier of pharmaceuticals, surgical consumables, laboratory chemicals, and equipment to all institutions administered by the Ministry of Health. Additionally, SPC supplies a significant portion of the private sector, holding a 30% market share. (spc.lk)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — State Pharmaceutical Corporation OF

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

SPC's sourcing strategy reveals a high concentration of imports from a select group of Indian suppliers. The top five suppliers account for 100% of SPC's pharmaceutical imports from India, indicating a strategic choice to maintain strong, stable relationships with these suppliers. This concentrated sourcing approach may offer benefits such as favorable pricing and consistent product quality. However, it also presents risks associated with over-reliance on a limited number of suppliers, which could impact supply chain resilience in the event of disruptions.

2Supply Chain Resilience

SPC's supply chain resilience is closely tied to its concentrated sourcing from a few Indian suppliers. While this strategy may streamline procurement processes, it also exposes SPC to potential risks if any of these suppliers face operational challenges or regulatory issues. The diversity of formulations imported suggests a degree of flexibility in product offerings, but the overall supply chain's robustness depends on the stability and reliability of these key suppliers.

3Strategic Implications

Importing Pharmaceuticals into Sri Lanka — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Sri Lanka

1Regulatory Authority & Framework

The National Medicines Regulatory Authority (NMRA) is the primary regulatory body overseeing the pharmaceutical sector in Sri Lanka. Established in 2015 through an Act of Parliament, the NMRA is responsible for ensuring the safety, efficacy, and quality of medicines, medical devices, and related products. It regulates the manufacturing, importation, distribution, and sale of these products within the country. (nmra.gov.lk)

2Import Licensing & GMP

Importers like SPC must obtain the necessary licenses from the NMRA to import pharmaceutical products into Sri Lanka. The NMRA requires that all imported medicines comply with Good Manufacturing Practices (GMP) standards. Recognized certifications include EU GMP, WHO GMP, and PIC/S standards. Importers are responsible for ensuring that their suppliers adhere to these standards to maintain the quality and safety of imported products. (nmra.gov.lk)

3Quality & Labeling

Imported pharmaceutical products must undergo batch testing and meet stability requirements as mandated by the NMRA. Labeling must be in the official language(s) of Sri Lanka, and products must comply with serialization mandates to ensure traceability and prevent counterfeit products from entering the market. These measures are in place to protect public health and maintain the integrity of the pharmaceutical supply chain. (nmra.gov.lk)

State Pharmaceutical Corporation OF — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

SPC's focus on importing products in the gastrointestinal and respiratory therapeutic categories aligns with prevalent health concerns in Sri Lanka. The significant importation of lactulose and terbutaline suggests a strategic response to the demand for treatments in these areas. This product strategy indicates SPC's commitment to addressing the nation's healthcare needs by providing essential medications that are both safe and effective.

2Sourcing Profile

SPC's sourcing strategy emphasizes the importation of generic drugs, particularly those manufactured in India. This approach allows SPC to offer cost-effective medications while maintaining quality standards. The corporation's focus on finished pharmaceutical formulations, rather than raw APIs or bulk drugs, suggests a preference for ready-to-use products that can be directly distributed to healthcare providers and consumers.

3Market Positioning

SPC serves a broad segment of the Sri Lankan pharmaceutical market, including public hospitals, private healthcare institutions, and retail pharmacies. Its role as the sole supplier to government health institutions and a significant supplier to the private sector positions SPC as a key player in both government tenders and wholesale distribution. This extensive reach underscores SPC's integral role in ensuring the availability of essential medications across the country.

Seller's Guide — How to Become a Supplier to State Pharmaceutical Corporation OF

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter SPC's supply chain, particularly if they can offer competitive pricing, high-quality products, and reliable delivery schedules. Diversifying SPC's supplier base could enhance its supply chain resilience and reduce dependency on a limited number of sources. For Indian exporters, establishing relationships with SPC could lead to increased market access and growth opportunities within Sri Lanka.

2Requirements & Qualifications

Indian exporters seeking to supply SPC must ensure that their products comply with the NMRA's GMP standards, which include EU GMP, WHO GMP, or PIC/S certifications. Additionally, products must meet labeling requirements, including the use of official languages and serialization mandates. Maintaining these standards is essential for gaining approval from the NMRA and entering the Sri Lankan market. (nmra.gov.lk)

3How to Approach

Indian exporters should initiate contact with SPC by demonstrating their compliance with NMRA standards and highlighting their product quality and reliability. Participating in tenders and responding to SPC's procurement processes can facilitate entry into the supply chain. Understanding the regulatory filing requirements and timelines set by the NMRA is crucial for a successful market entry strategy. Building a strong relationship with SPC and maintaining consistent product quality will be key to establishing a long-term partnership.

Frequently Asked Questions — State Pharmaceutical Corporation OF

What products does State Pharmaceutical Corporation OF import from India?

State Pharmaceutical Corporation OF imports 2 pharmaceutical products across 2 categories. Top imports: Lactulose ($100.0K), Terbutaline ($54.6K).

Who supplies pharmaceuticals to State Pharmaceutical Corporation OF from India?

State Pharmaceutical Corporation OF sources from 8 verified Indian suppliers. The primary supplier is Glenmark Pharmaceuticals Limited (32.9% of imports, $267.1K).

What is State Pharmaceutical Corporation OF's total pharmaceutical import value?

State Pharmaceutical Corporation OF's total pharmaceutical import value from India is $154.6K, based on 5 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does State Pharmaceutical Corporation OF focus on?

State Pharmaceutical Corporation OF imports across 2 categories. The largest: Gastrointestinal (64.7%), Respiratory & OTC (35.3%).

Get Full State Pharmaceutical Corporation OF Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.